secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2023-01-20T23:59:59+00:00
Accession:  0001214659-23-000871
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro updates corporate presentation; no material new details disclosed
--------------------------------------------------------------------------------

- Alzamend Neuro refreshed its investor presentation for meetings with investors and analysts.
- Presentation covers the company's pipeline for Alzheimer's and psychiatric disorders.
- No financial results, guidance, or specific clinical milestones were reported in the filing.
- The update is a routine disclosure with no identified material changes to the company's strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923000871/0001214659-23-000871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923000871/r1192328k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-23-000871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer